Flagship’s Jim Matheson and David Barry named to Biofuels Digest’s list of “The Top 100 People in Bioenergy.” Also listed are three Flagship portfolio company CEOs: Bill Sims of Joule Unlimited, Bill Haywood of LS9 and Bill Brady of Mascoma.

Flagship’s Jim Matheson and David Barry named to Biofuels Digest’s list of “The Top 100 People in Bioenergy.” Also listed are three Flagship portfolio company CEOs: Bill Sims of Joule Unlimited, Bill Haywood of LS9 and Bill Brady of Mascoma.

October 11, 2010

An excerpt from the announcement is below. Read the full original posting here, with a link to the entire Top 100 list.
 

AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals Regains Worldwide Rights to Develop and Commercialize Anti-HGF Antibody Candidate AV-299

AVEO Pharmaceuticals Regains Worldwide Rights to Develop and Commercialize Anti-HGF Antibody Candidate AV-299

September 30, 2010

CAMBRIDGE, Mass., September 30, 2010 - AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate. 

Advanced Electron Beams, Inc

Advanced Electron Beams Names Richard M. Feldt as Chief Executive Officer

Advanced Electron Beams Names Richard M. Feldt as Chief Executive Officer

September 28, 2010
Richard M. Feldt, highly experienced & respected clean technology executive, joins Advanced Electron Beams to lead company through next phase of growth.
 
CGI Pharmaceuticals, Inc.

Cellular Genomics Signs Kinase Research and Development Collaboration Agreement with Schering AG

Cellular Genomics Signs Kinase Research and Development Collaboration Agreement with Schering AG

December 12, 2002

BRANFORD, Conn., Dec. 12 /PRNewswire/ -- Cellular Genomics Inc. (CGI) today announced that it has entered into a collaborative research agreement with Schering AG (SHR), in which CGI will apply its proprietary chemical genetics technologies to the study of an undisclosed target kinase selected by Schering. Under the terms of the agreement, CGI will receive an undisclosed upfront fee and a series of milestone payments over a period of 15 months.

Renovis

Renovis, Inc. Announces Acquistion of Assets from Centaur Pharmaceutials Inc.

Renovis, Inc. Announces Acquistion of Assets from Centaur Pharmaceutials Inc.

December 12, 2002

Acquisition Accelerates Company's Drug Discovery and Clinical Development Programs

Joule Unlimited, Inc.

Game Changer? Joule Unlimited looks to revolutionize fuel industry

Game Changer? Joule Unlimited looks to revolutionize fuel industry

September 3, 2010

Boston Business Journal - by Kyle Alspach

Friday, September 3, 2010

Lots of up-and-coming tech companies claim to have “game-changing” technologies. Fewer claim to have world-changing ones.

Cambridge-based Joule Unlimited Inc., which aims to use advances in biotech and solar energy to create new types of renewable fuel, falls into the bolder category.

Helicos BioSciences Corporation

Helicos BioSciences Files Patent Infringement Lawsuit Against Pacific Biosciences

Helicos BioSciences Files Patent Infringement Lawsuit Against Pacific Biosciences

September 8, 2010

CAMBRIDGE, Mass., Sep 08, 2010 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent infringement. The lawsuit, filed in the United States District Court for the District of Delaware, accuses PacBio of infringing four patents and seeks injunctive relief and monetary damages.

Acceleron Pharma, Inc.

Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire on Novel Muscle Therapeutics for Orphan Diseases

Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire on Novel Muscle Therapeutics for Orphan Diseases

September 9, 2010

$498 Million Deal Grants Shire Exclusive Ex-North American Rights to Acceleron’s Innovative Class of ActRIIB Molecules Including ACE-031, Currently in Phase 2 Trials to Treat Patients with Duchenne Muscular Dystrophy

Joule Unlimited, Inc.

Joule Awarded Patent on Renewable Diesel Production from Sunlight and CO2

Joule Awarded Patent on Renewable Diesel Production from Sunlight and CO2

September 14, 2010

Breakthrough process overcomes the costs and complexities of biomass-to-fuel

TripAdvisor LLC

Kennedy Space Center tops the list of favorite U.S. family summer attractions researched on the Web

Kennedy Space Center tops the list of favorite U.S. family summer attractions researched on the Web

June 24, 2003

TripAdvisor study reveals national parks and aquariums dominate the list of favorite "Things to Do" on family vacations this summer